enVVeno Medical Corp (NVNO) AI Dilution Summary
Updated Nov 3, 2026
The company is funding itself through its active ATM program with Ladenburg Thalmann & Co. Inc., authorised to $50,000,000, through which 117,000 shares were sold since the program began through 2026-09-30; sales after 2026-09-30 are not yet reported. Cash was $18,472,000 at 2026-09-30 against estimated monthly burn of $1,107,222, and the most recent capital raised was ATM sales through 2026-09-30.